Pasithea Therapeutics KTTAW
NASDAQ KTTAW
$0.00 0.00 (-36.36%)
As of: Sep 9, 2026 · 3:56 PM EDT

Pasithea Therapeutics Corp. (KTTAW) Other Working Capital Changes (2022 - 2024)

Pasithea Therapeutics' (KTTAW) quarterly Other Working Capital Changes came in at -$377929.0 in Q2 2026, down 747.15% year-over-year from $58399.3 in Q2 2025, and down 3088.29% quarter-over-quarter from $12647.0 in Q1 2026.

Analysis

Pasithea Therapeutics Corp. (KTTAW) Other Working Capital Changes (2022 - 2024) Analysis & Trends

Pasithea Therapeutics has disclosed Other Working Capital Changes across 5 years of filings, most recently posting -$377929.0 for Q2 2026.

  • In Q2 2026, Other Working Capital Changes fell 747.15% year-over-year to -$377929.0; the TTM figure through Jun 2026 stood at -$70901.0 (down 637.62% YoY), while the FY2025 annual figure was $269278.0, up 12004.42% from the prior year.
  • Other Working Capital Changes came in at -$963.0 for Q2 2024 at Pasithea Therapeutics, up from -$1446.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $574684.0 in Q3 2022 to a low of -$377929.0 in Q2 2026.
  • Average Other Working Capital Changes over 5 years is $10894.5, with a median of -$3189.5 recorded in 2024.
  • The largest YoY upside for Other Working Capital Changes was 33736.21% in 2025 against a maximum downside of 1241.2% in 2025.
  • Over 2 years, Other Working Capital Changes stood at $561520.0 in 2022, then plunged by 100.17% to -$963.0 in 2024.
  • Per Business Quant data, the three most recent Other Working Capital Changes figures were -$963.0 in Q2 2024, -$1446.0 in Q1 2024, and $561520.0 in Q4 2022.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -963.00
Jun 30, 2024 -963.00
Mar 31, 2024 -1,446.00
Mar 31, 2024 -1,446.00
Dec 31, 2022 561,520.00
Dec 31, 2022 561,520.00
Sep 30, 2022 -48,914.00
Sep 30, 2022 -48,914.00